4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000129
Director sold 786 shares at $21.00 ($16,506)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pauls Matthew Director | 2026-10-02 | Sale 10b5-1 | −786 | $21.00 | $16,506 | 13,578 | D: show line 1 in the form |
| Open-market sales · 786 sh · avg $21.00 · $16,506 | |||||||
Loading xslF345X06/wk-form4_1791323618.xml…